11:10 AM EST, 12/11/2024 (MT Newswires) -- Eli Lilly ( LLY ) is enhancing accessibility to single-dose vials of Zepbound via a collaboration with telehealth service provider Ro, which announced the offering of the weight-loss drug on its platform on Wednesday.
Ro said the vials will be delivered directly to clinically eligible patients.
An Eli Lilly ( LLY ) representative and Ro did not immediately reply to MT Newswires' requests for information on the terms of the partnership.
Ro Chief Executive Zach Reitano was quoted in a Bloomberg report as saying that the company has "no financial arrangement" with Eli Lilly ( LLY ) regarding the Zepbound offering on its site.
Price: 790.63, Change: -8.96, Percent Change: -1.12